|
Characteristic | Results | |
|
Age | 63.43 years ± 14.07 years [CI 60.98–65.89] | |
Sex | Males (n = 81; 62.8%); females (n = 48; 37.2%) | |
Ethnicity | Indigenous (n = 23; 17.8%); non-Indigenous (n = 106; 82.2%) | |
Type of diabetes | Type 1 (n = 22; 17.1%); type 2 (n = 107; 82.9%) | |
Type of ulcer | Ischaemic (n = 57; 44.2%); nonischaemic (n = 72; 55.8%) | |
|
Clinical outcome | Total study sample | Ischaemic ulcer cohort | Nonischaemic ulcer cohort | value, OR [CI] |
|
Amputation | (n = 44)—34.1% | (n = 20)—35.1% | (n = 24)—33.3% | p = 0.84, 1.1 [0.52–2.25] |
Minor amputation | (n = 35)—27.13% | (n = 15)—42.9% | (n = 20)—57.1% | p = 0.50, 0.9 [0.14–2.62] |
Major amputation | (n = 9)—6.98% | (n = 5)—55.5% | (n = 4)—44.4% | p = 0.50, 1.5 [0.46–4.84] |
Indigenous amputations | (n = 13)—56.5% | (n = 9)—69.2% | (n = 4)—30.8% | p = 0.94, 0.9 [0.17–5.07] |
Ischaemic heart disease | (n = 61)—47.3% | (n = 31)—54.4% | (n = 30)—41.7% | p = 0.15, 1.7 [0.83–3.36] |
Acute myocardial infarction | (n = 27)—20.9% | (n = 15)—26.3% | (n = 12)—16.7% | p = 0.18, 1.8 [0.76–4.20] |
Cerebrovascular accidents | (n = 19)—14.7% | (n = 11)—19.3% | (n = 8)—11.1% | p = 0.19, 1.9 [0.71–5.13] |
Chronic kidney disease | (n = 52)—40.3% | (n = 27)—47.4% | (n = 25)—34.7% | p = 0.20, 1.6 [0.78–3.23] |
Dialysis | (n = 7)—5.4% | (n = 4)—7.0% | (n = 3)—4.2% | p = 0.48, 1.7 [0.37–8.09] |
Peripheral vascular disease | (n = 94)—72.9% | (n = 44)—77.2% | (n = 50)—69.4% | p = 0.33, 1.5 [0.67–3.30] |
|